Salud financiera de hoja de balance de Astec LifeSciences
Salud financiera controles de criterios 1/6
Astec LifeSciences tiene un patrimonio de los accionistas total de ₹2.9B y una deuda total de ₹5.0B, lo que sitúa su ratio deuda-patrimonio en 171.5%. Sus activos y pasivos totales son ₹8.8B y ₹5.9B respectivamente.
Información clave
171.5%
Ratio deuda-patrimonio
₹5.00b
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | ₹20.68m |
| Patrimonio | ₹2.92b |
| Total pasivo | ₹5.90b |
| Activos totales | ₹8.82b |
Actualizaciones recientes sobre salud financiera
Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly
Jun 28
Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?
Dec 13Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
May 02Recent updates
Shareholders May Be Wary Of Increasing Astec LifeSciences Limited's (NSE:ASTEC) CEO Compensation Package
Jul 23Market Participants Recognise Astec LifeSciences Limited's (NSE:ASTEC) Revenues Pushing Shares 28% Higher
Jul 03Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable
Mar 15Astec LifeSciences (NSE:ASTEC) Could Be Struggling To Allocate Capital
May 17Shareholders Are Optimistic That Astec LifeSciences (NSE:ASTEC) Will Multiply In Value
Oct 14We Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease
Jul 27Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly
Jun 28A Look At The Intrinsic Value Of Astec LifeSciences Limited (NSE:ASTEC)
Jun 03Analysts Just Published A Bright New Outlook For Astec LifeSciences Limited's (NSE:ASTEC)
May 08Astec LifeSciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 06Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)
Jan 25Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?
Dec 13We Take A Look At Why Astec LifeSciences Limited's (NSE:ASTEC) CEO Has Earned Their Pay Packet
Jul 21Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
May 02The Trend Of High Returns At Astec LifeSciences (NSE:ASTEC) Has Us Very Interested
Apr 17Do Astec LifeSciences's (NSE:ASTEC) Earnings Warrant Your Attention?
Apr 02Is Astec LifeSciences Limited's (NSE:ASTEC) Shareholder Ownership Skewed Towards Insiders?
Mar 18Have Insiders Been Selling Astec LifeSciences Limited (NSE:ASTEC) Shares?
Mar 05Did You Miss Astec LifeSciences' (NSE:ASTEC) Whopping 481% Share Price Gain?
Feb 20A Look At Astec LifeSciences' (NSE:ASTEC) CEO Remuneration
Feb 08Declining Stock and Solid Fundamentals: Is The Market Wrong About Astec LifeSciences Limited (NSE:ASTEC)?
Jan 28What Does Astec LifeSciences Limited's (NSE:ASTEC) Share Price Indicate?
Jan 17
Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)
Jan 08I Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease
Dec 28Is Astec LifeSciences Limited (NSE:ASTEC) Popular Amongst Insiders?
Dec 18Astec LifeSciences (NSE:ASTEC) Is Growing Earnings But Are They A Good Guide?
Dec 07Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (₹3.0B) de ASTEC no cubren sus pasivos a corto plazo (₹3.7B).
Pasivo a largo plazo: Los activos a corto plazo de ASTEC (₹3.0B) superan a sus pasivos a largo plazo (₹2.2B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de ASTEC (170.8%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de ASTEC ha crecido de 102.5% a 171.5% en los últimos 5 años.
Cobertura de la deuda: La deuda de ASTEC no está bien cubierta por el flujo de caja operativo (2.4%).
Cobertura de intereses: Datos insuficientes para determinar si los pagos de intereses de ASTEC sobre su deuda están bien cubiertos por el EBIT.